These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26504821)

  • 1. Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review.
    van Gestel NA; Geurts J; Hulsen DJ; van Rietbergen B; Hofmann S; Arts JJ
    Biomed Res Int; 2015; 2015():684826. PubMed ID: 26504821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections - A Multinational Study.
    Lindfors N; Geurts J; Drago L; Arts JJ; Juutilainen V; Hyvönen P; Suda AJ; Domenico A; Artiaco S; Alizadeh C; Brychcy A; Bialecki J; Romanò CL
    Adv Exp Med Biol; 2017; 971():81-92. PubMed ID: 28050878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study.
    Romanò CL; Logoluso N; Meani E; Romanò D; De Vecchi E; Vassena C; Drago L
    Bone Joint J; 2014 Jun; 96-B(6):845-50. PubMed ID: 24891588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up.
    Kojima KE; de Andrade E Silva FB; Leonhardt MC; de Carvalho VC; de Oliveira PRD; Lima ALLM; Roberto Dos Reis P; Silva JDS
    Injury; 2021 Jul; 52 Suppl 3():S23-S28. PubMed ID: 34116851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads.
    Gergely I; Zazgyva A; Man A; Zuh SG; Pop TS
    Acta Microbiol Immunol Hung; 2014 Jun; 61(2):145-60. PubMed ID: 24939683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority trial.
    Tanner MC; Heller R; Westhauser F; Miska M; Ferbert T; Fischer C; Gantz S; Schmidmaier G; Haubruck P
    Trials; 2018 May; 19(1):299. PubMed ID: 29843766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro.
    Coraça-Huber DC; Fille M; Hausdorfer J; Putzer D; Nogler M
    J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review.
    Bigoni M; Turati M; Zanchi N; Lombardo AS; Graci J; Omeljaniuk RJ; Zatti G; Gaddi D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(2 Suppl):240-251. PubMed ID: 30977891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
    Malat TA; Glombitza M; Dahmen J; Hax PM; Steinhausen E
    Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
    Lindfors NC; Hyvönen P; Nyyssönen M; Kirjavainen M; Kankare J; Gullichsen E; Salo J
    Bone; 2010 Aug; 47(2):212-8. PubMed ID: 20624692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and complications of S53P4 bioactive glass in chronic osteomyelitis and septic non-unions: a retrospective single-center study.
    Gatti SD; Gaddi D; Turati M; Leone G; Arts JJ; Pessina F; Carminati M; Zatti G; De Rosa L; Bigoni M
    Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):489-499. PubMed ID: 38195783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilisation of bioactive glass S53P4 inside an induced membrane for severe bone defect with high risk of infection: a multi-center preliminary experience.
    Aurégan JC; Villain B; Glombitza M; Blokhuis T; Heinänen M; Bégué T
    Injury; 2022 Oct; 53 Suppl 2():S13-S19. PubMed ID: 35871084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstruction of Vertebral Bone Defects using an Expandable Replacement Device and Bioactive Glass S53P4 in the Treatment of Vertebral Osteomyelitis: Three Patients and Three Pathogens.
    Kankare J; Lindfors NC
    Scand J Surg; 2016 Dec; 105(4):248-253. PubMed ID: 26929284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive glass for long bone infection: a systematic review.
    Aurégan JC; Bégué T
    Injury; 2015 Dec; 46 Suppl 8():S3-7. PubMed ID: 26747915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenic protein expression and bone formation are induced by bioactive glass S53P4 scaffolds in vivo.
    Björkenheim R; Strömberg G; Ainola M; Uppstu P; Aalto-Setälä L; Hupa L; Pajarinen J; Lindfors NC
    J Biomed Mater Res B Appl Biomater; 2019 Apr; 107(3):847-857. PubMed ID: 30194906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.
    Drago L; Romanò D; De Vecchi E; Vassena C; Logoluso N; Mattina R; Romanò CL
    BMC Infect Dis; 2013 Dec; 13():584. PubMed ID: 24325278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage.
    Sarin J; Grénman R; Aitasalo K; Pulkkinen J
    Ann Otol Rhinol Laryngol; 2012 Sep; 121(9):563-9. PubMed ID: 23012893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regeneration of Cystic Bone Cavities and Bone Defects With Bioactive Glass S53P4 in the Upper and Lower Jaws.
    Stoor P; Apajalahti S; Kontio R
    J Craniofac Surg; 2017 Jul; 28(5):1197-1205. PubMed ID: 28538076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAG-S53P4 as bone graft extender and antimicrobial activity against gentamicin- and vancomycin-resistant bacteria.
    Bortolin M; Romanò CL; Bidossi A; Vecchi E; Mattina R; Drago L
    Future Microbiol; 2018 Apr; 13():525-533. PubMed ID: 29521127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIOACTIVE GLASS S53P4: a new opportunity for the treatment in the diabetic foot osteomyelitis.
    De Giglio R; Stefani I; Mondello T; De Filippis G; Mazzone A
    Eur J Intern Med; 2018 Aug; 54():e15-e16. PubMed ID: 29709419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.